Zunveyl, an oral medication, is a better-tolerated version of galantamine for managing mild to moderate Alzheimer's symptoms.

Based on the data provided by the drug's manufacturer, Eli Lilly, for the FDA to review, it’s the most effective drug yet in slowing cognitive decline associated with the disease. Studies ...

Medical advances make pills to treat Alzheimer’s disease viable, though challenges remain in sharing gains globally ...

One expert called it the most important dementia ... There have been no effective new treatments and some pharmaceutical companies have dropped out of the dementia drug race.

The research breakthrough ends decades of failure and shows a new era of drugs to treat Alzheimer's - the most common form of dementia - is possible. Yet the medicine, lecanemab, has only a small ...

Previous research has associated sleep medications with other health risks, such as falls, fractures, car accidents, and ...

Warnings have been issued over commonly prescribed drugs could increase risk of dementia following a scientific study. Research suggested that regular use of certain types of commonly-prescribed drugs ...